Management and outcomes of congenital nasolacrimal duct obstruction in trisomy 21 patients vs. non-trisomy 21 patients within a paediatric population: a 5-year follow-up.

MLA

Fenech, Matthew T., et al. “Management and Outcomes of Congenital Nasolacrimal Duct Obstruction in Trisomy 21 Patients vs. Non-Trisomy 21 Patients within a Paediatric Population: A 5-Year Follow-Up.” Orbit, vol. 44, no. 1, Feb. 2025, pp. 10–17. EBSCOhost, https://doi.org/10.1080/01676830.2024.2365830.

APA

Fenech, M. T., Raj, A., Dodeja, R., & Yeo, D. (2025). Management and outcomes of congenital nasolacrimal duct obstruction in trisomy 21 patients vs. non-trisomy 21 patients within a paediatric population: a 5-year follow-up. Orbit, 44(1), 10–17. https://doi.org/10.1080/01676830.2024.2365830

Chicago

Fenech, Matthew T., Ankur Raj, Rutika Dodeja, and Damien Yeo. 2025. “Management and Outcomes of Congenital Nasolacrimal Duct Obstruction in Trisomy 21 Patients vs. Non-Trisomy 21 Patients within a Paediatric Population: A 5-Year Follow-Up.” Orbit 44 (1): 10–17. doi:10.1080/01676830.2024.2365830.